Pharmaceutics_R&D
3.9K views | +0 today
Follow
Pharmaceutics_R&D
Pharmaceutical companies R&D specifically in neuroscience, CNS disease, pain and electrophysiology
Your new post is loading...
Your new post is loading...
Scooped by Julien Hering, PhD
Scoop.it!

Biotech reels over patent ruling

Biotech reels over patent ruling | Pharmaceutics_R&D | Scoop.it

Firms fight for the right to patent natural products and processes. 

 

Guidelines that forbid patents on a wide array of natural products, phenomena and principles have many in the biotechnology and pharmaceutical industries worried about the future of their business. (...) - by Erika Check-Hayden, Nature, 08 July 2014

more...
No comment yet.
Scooped by Julien Hering, PhD
Scoop.it!

The Biotech Industry is facing a Patent Cliff and True Disruption – Biotech Part 3 of 6

The Biotech Industry is facing a Patent Cliff and True Disruption – Biotech Part 3 of 6 | Pharmaceutics_R&D | Scoop.it

In February of 2011, Pfizer announced the closing of its R&D center in Sandwich, Kent, United Kingdom.  That center of excellence was a core part of the company’s drug development program.  It employed 2,400 people, covered 80 acres and became known as the “the home of Viagra.”  While Viagra was home grown and not venture backed, the closure of the Pfizer campus signaled a paradigm shift migrating big pharma, in-house R&D to satellite / outsourced drug discovery.  Many of these companies are virtual and have a lean management, contractors doing much of the work and VCs playing a critical role forming and managing these companies.  R&D spending for the pharmaceutical industry fell to $61bn in 2011, down from $68bn in 2010, down again from $70bn in 2009 and 2008 annually (...) -  by Andrew Romans, The Founders Club, 19 December 2012

more...
No comment yet.